Acrobiosystems Co

Acrobiosystems Co Days Inventory Outstanding

The Days Inventory Outstanding (DIO) of Acrobiosystems Co (301080.SZ) as of Oct 17, 2026 is 1,298.62. In the previous year, Days Inventory Outstanding (DIO) was 1,230.28 — a change of 5.55% (higher).

Days Inventory Outstanding

1,298.62

YoY

5.55%

Last updated:

Days Inventory Outstanding (DIO) of Acrobiosystems Co is 2025 1,298.62 . Days Inventory Outstanding (DIO) of Acrobiosystems Co was 2024 1,230.28 . It decreases by 5.55% higher compared to the previous year.

The Acrobiosystems Co Days Inventory Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Inventory Outstanding
Date
Days Inventory Outstanding
Jan 1, 2018
726.95 CNY
Jan 1, 2019
660.67 CNY
Jan 1, 2020
596.57 CNY
Jan 1, 2021
793.05 CNY
Jan 1, 2022
955.48 CNY
Jan 1, 2023
1,050.83 CNY
Jan 1, 2024
1,230.28 CNY
Jan 1, 2025
1,298.62 CNY
The Acrobiosystems Co Days Inventory Outstanding history
YEARDays Inventory OutstandingYoY
1,298.62+5.55%
1,230.28+17.08%
1,050.83+9.98%
955.48+20.48%
793.05+32.93%
596.57-9.70%
660.67-9.12%
726.95—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Acrobiosystems Co Stock analysis

What does Acrobiosystems Co do? Acrobiosystems Co Ltd is a biotechnology company based in Beijing, China, operating within the Health Care sector. The company specializes in the development of biomedicine and bio-protein technology, focusing on recombinant proteins, detection services, and related products such as kits, antibodies, fillers, and culture media. With 597 full-time employees, Acrobiosystems provides services and products primarily for research and development (R&D) and production processes in the pharmaceutical and biotechnology industries. Its offerings support early drug discovery, verification, drug screening, optimization, diagnostic reagent development, and preclinical and clinical trials for various diseases, including tumors, autoimmune disorders, cardiovascular conditions, and infectious diseases. The company completed its initial public offering (IPO) on October 18, 2021, and is listed under the ticker symbol 301080.SZ with ISIN CNE100004S13. Acrobiosystems operates from its headquarters in Beijing, leveraging its technological expertise to contribute to advancements in drug development and diagnostic solutions. The company's website is https://www.acrobiosystems.cn/. Acrobiosystems Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Acrobiosystems Co stock

Days Inventory Outstanding (DIO) of Acrobiosystems Co is 1,298.62 in 2025.

Days Inventory Outstanding (DIO) of Acrobiosystems Co changed from 1,230.28 to 1,298.62, representing a 5.55% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Days Inventory Outstanding (DIO) Acrobiosystems Co since 2006 – with annual values, charts, and detailed analysis.

DIO measures the average number of days inventory is held before being sold. Lower values indicate more efficient inventory management.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Inventory Outstanding (DIO)'s Acrobiosystems Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Inventory Outstanding (DIO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Inventory Outstanding (DIO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Profitability — Acrobiosystems Co

ROEROAROCEROICAsset TurnoverInventory TurnoverReceivables TurnoverDays Sales OutstandingDays Inventory OutstandingDays Payable OutstandingCash Conversion CycleCROICGross Profit/AssetsFixed Asset TurnoverEquity TurnoverWorking Capital TurnoverPayables TurnoverCapital IntensityReceivables/RevenueInventory/RevenueEBIT/Assets

All Key Metrics — Acrobiosystems Co